Walleye Capital’s MDxHealth MDXH Stock Holding History

Walleye Capital’s Portfolio MDXH Stock Details MDXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,467	Closed	-$53.3K	–	4902
2025 Q3	$53.3K	Buy	+11,467	New	+$35.3K	﹤0.01%	3984

Other funds holding MDXH

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walleye Capital's MDXH Position: Q4 2025 in Review

Walleye Capital sold out of MDxHealth (MDXH) in Q4 2025, closing a stake of 11,467 shares — an estimated $53.3K sold.

Walleye Capital first reported a position in MDXH in Q3 2025 and held it in 1 quarter. The position peaked at $53.3K in Q3 2025. 56 funds tracked by Wall St. Rank hold MDXH as of Q4 2025.

Walleye Capital reported no remaining MDxHealth position as of Q4 2025 after selling out during the quarter.
Walleye Capital sold 11,467 MDxHealth shares in Q4 2025, an estimated $53.3K.
Walleye Capital first reported a position in MDxHealth in Q3 2025 and held it in 1 quarter.
Walleye Capital's MDxHealth position peaked at $53.3K in Q3 2025.
56 funds tracked by Wall St. Rank held MDxHealth as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.